Professor Glenn A. Okun
The Rabid Capitalist: The Big Point is a summary of a detailed note available to paid subscribers.
Despite the SpaceX IPO, the U.S. equity market remains a reluctant liquidity source for venture capitalists. A drastic reversal, which is badly needed for venture capital asset class to restore its allure, is not a short-term prospect.
Complete content is available for a $15 monthly subscription. Click here to subscribe:
The Rabid Capitalist 
Leave a comment